---
$id: https://graph.org.ai/products/commodity/51141504
$type: Product
source: UNSPSC
code: "51141504"
title: "Lamotrigine"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lamotrigine

**UNSPSC Code**: 51141504
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C9H7Cl2N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U3H27498KS, chemically known as 1,2,4-triazine-3,5-diamine, 6-(2,3-dichlorophenyl)- but generally known as lamotrigine, which bears US NIH Compound Identifier 3878. European Medicines Agency schedules Lamotrigine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08393MIG. The term LAMOTRIGINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules lamotrigine in its Anatomical Therapeutic Chemical (ATC) Classification. LAMOTRIGINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lamotrigine under HS 29336980 and SITC 51576. As of Q4 2014, LAMOTRIGINE remains the US FDA Preferred Term for this commodity. Lamotrigine bears US NLM identifiers UMLS ID C0678180 and NCI Concept Code C38703. SMILES: CLC1C(C2NNC(NC2N)N)CCCC1CL.

